This EAE model involves the transfer of MOG-specific antibodies isolated from sera of MS patients into huFcγR mice38 that have been immunized with the weakly encephalitogenic human MOG peptide (residues 35–55; hMOG35-55).14 This evidence concerns the gene MOG and myeloid sarcoma.